News Daily News US Prescriptions During COVID-19: Hydroxychloroquine Soars, CVD Drugs Stable Shelley Wood May 29, 2020
News Daily News Dose of Reality? Hydroxychloroquine and Chloroquine Again Disappoint in COVID-19 Michael O'Riordan May 26, 2020
News Daily News More Evidence of Lower Fracture Risk With DOACs Versus Warfarin Todd Neale May 19, 2020
News Conference News HRS 2020 PINNACLE FLX: New-Generation Watchman Has High Closure Rates, Good Safety Todd Neale May 15, 2020
News Daily News HRS 2020 ‘Silent’ Brain Infarcts Common, Tied to Cognitive Decline in A-fib Todd Neale May 14, 2020
News Features Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance Shelley Wood April 29, 2020
News Features Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms Caitlin E. Cox April 23, 2020
News Daily News How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions Michael O'Riordan April 22, 2020
News Conference News ACC 2020 Aspirin Okay for Up to 30 Days in A-fib Patients After ACS or PCI: AUGUSTUS Todd Neale April 03, 2020
News Conference News ACC 2020 A-fib Patients Undergoing TAVR Do Better With OAC Alone: POPular TAVI Todd Neale March 29, 2020
News Conference News ACC 2020 Low Mortality Rates Seen With Andexanet Alfa for Factor Xa-Related Bleeds Todd Neale March 25, 2020
News Daily News More Support for DOAC-Based Double Therapy After PCI for A-fib Patients Todd Neale March 16, 2020
News Daily News Choosing a DOAC? Apixaban May Have an Edge Over Rivaroxaban Todd Neale March 09, 2020
News Daily News Antiplatelets Add Risk in Newly Diagnosed A-fib Patients: GARFIELD-AF Caitlin E. Cox March 02, 2020
News Daily News New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib Shelley Wood February 28, 2020
News Conference News ISC 2020 Optimal Time to Start Anticoagulation After Stroke Remains Unclear Todd Neale February 27, 2020
News Daily News Ticagrelor Hits Mark in Large Stroke Study: THALES Top-line Results Michael O'Riordan January 27, 2020